Zerion Pharma A/S is a Danish pharmaceutical company aspiring to transform the pharmaceutical landscape for the formulation of poorly soluble drugs. Its pioneering Dispersome® technology greatly enhances the solubility, bioavailability, and therapeutic potential of oral drugs. Based on the novel excipient beta-lactoglobulin (BLG), Dispersome® enables stable, high-load amorphous formulations that improve patient outcomes.